How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

CN

OOTC:CNBX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

CN

CNBX Pharmaceuticals IncOOTC CNBX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is CNBX undervalued compared to its fair value?

The fair value of CNBX stock is hidden USD. Relative to the market price of 0.006 USD CNBX Pharmaceuticals Inc is hidden.

CNBX Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of cannabinoid-based products and technologies for the treatment of cancer....[More about valuation]

CNBX Pharmaceuticals Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0 $B

Price:

0.006 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.011

FINANCIALS

CNBX Pharmaceuticals financial for reporting period

Income Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0002 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0003 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0 B 100%
-0.0002 B -508%
-0.0003 B -801%

Balance Sheet

0.0002 B
-0.0024 B


Financial Position Analysis

Assets

0.0002 B
Current Assets
0.0002 B
Total non-current assets

Total current liabilities
0.0025 B
Total non-current liabilities

Cash Flow Statement

-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

CNBX Pharmaceuticals fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-288 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is CNBX attractive for investment based on fundamental analysis?

CNBX stock rating is hidden. CNBX Pharmaceuticals is a hidden by Eyestock methodology.

Get CNBX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-228

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

0.088

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

CNBX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for CNBX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

CNBX Pharmaceuticals Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

CNBX Pharmaceuticals Inc dividends

CNBX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About CNBX stock

About the company CNBX Pharmaceuticals Inc

Market cap $B

0

Dividend yield

Shares outstanding

1.25793 B

CNBX Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of cannabinoid-based products and technologies for the treatment of cancer. The Company's lead product candidate, Cannabics SR, is an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS). Its anti-neoplastic drug candidate under development for colorectal cancer (CRC) is RCC-33, a therapy being developed primarily in two settings: one to reduce tumor cell activity in CRC patients as a standalone in neoadjuvant treatment at the time after colonoscopy, prior to cancer staging, and another for patients with refractory to therapy and adjuvant to surgery also at the time after colonoscopy. It is focused on Phase I/II (a) clinical studies for Cannabics SR and RCC-33. It also has several other drug candidates under development, including PLP-33, BRST-33, MLN-33 and PRST-33.

CNBX profile

  • Ticker

    CNBX

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    02 July 2007

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    5

  • City

    Bethesda

  • Address

    #3 Bethesda Metro Center, Suite 700

  • Cusip

    13764M209